Recent studies have shown that the PI3K/AKT/mTOR pathway was activated in gastric cancer and that activation of this pathway was correlated with metastasis, poor prognosis and lower survival in gastric cancer patients [43]. The gene discussed is AKT1; the disease is gastric cancer.